設計、合成新型Thalidomide衍生物及評估抗發炎活性

Design, Synthesis and Anti-inflammatory Activity Evaluation of Novel Thalidomide Derivatives

湯鎧瑋(Kai-Wei Tang)

指導教授 ： 曾志華

高雄醫學大學/藥學院/藥學系碩士班/碩士(2017年)

摘要

Thalidomide為glutamic acid的合成衍生物，目前已被研究出具有多種藥理機轉，像是抗發炎、抗血管增生以及免疫調節的作用，現今多用於治療多種癌症及免疫性疾病，但臨床上仍然有許多副作用需改善。本研究的目的為設計、合成出新一代thalidomide的衍生物，針對glutarimide ring上作修飾，在氮原子上藉由一段spacer連接疏水性基團，並探討其抗發炎活性。其中，我們發現化合物38針對IL-6以及TNF-兼具有高度的抑制效果。未來我們將繼續針對化合物38研究出更詳細的藥理機轉，或將其衍生，希望能開發出具有低副作用、高度抗發炎活性潛力之藥物。

關鍵字

Thaliodomide衍生物 ； 抗發炎

並列摘要

Thalidomide, a synthetic glutamic acid derivative, have been demonstrated to possess various pharmacological effects such as anti-inflammatory, anti-angiogenetic, and immunomodulatory activities. It is widely used nowadays in clinical to treat cancers and immunology diseases. There are, however, still a lot of side effects exhibited by the treatment of thalidomide, including severe teratogenicity which needed to be improved. In this study, we have designed and synthesized novel thalidomide derivatives, which added different substituted aryl groups to glutarimide ring on the thalidomide through different type of spacers. Among them, compound 38 demonstrated an excellent inhibition in both IL-6 and TNF-. We believe that compound 38 can serve as an excellent lead for further development of potential drug candidates.

並列關鍵字

Thalidomide Derivatives ； Anti-inflammatory

參考文獻

1. Randall, T. Thalidomide has 37-year history. JAMA 1990, 263, 1474.

2. Koren , G.；Pastuszak , A.；Ito , S. Drugs in Pregnancy. N Engl J Med 1998, 338, 1128-37.

3. Sheskin, J. Thalidomide in the Treatment of Lepra Reactions. Clin Pharmacol Ther 1965, 6, 303-6.

4. Sampaio, E. P.；Kaplan, G.；Miranda, A.；Nery, J. A.；Miguel, C. P.；Viana, S. M.；Sarno, E. N. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 1993, 168, 408-14.

6. Rajkumar, S. V.；Blood, E.；Vesole, D.；Fonseca, R.；Greipp, P. R.；Eastern Cooperative Oncology, G. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 2006, 24, 431-6.